OCUL
Ocular Therapeutix Inc
NASDAQ: OCUL · HEALTHCARE · BIOTECHNOLOGY
$9.21
-1.18% today
Updated 2026-04-29
Market cap
$2.00B
P/E ratio
—
P/S ratio
38.59x
EPS (TTM)
$-1.42
Dividend yield
—
52W range
$6 – $16
Volume
4.9M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
3.3
Growth
D5.8
Quality
C+2.5
Profitability
F5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
-2.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$26.00
+182.30%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
4 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Altman Z -2.07 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-57.09M
- Revenue declining -22.40% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $51.49M | $58.44M | $63.72M | $51.82M | $51.95M |
| Net income | $-71.04M | $-80.74M | $-193.51M | $-265.94M | $-64.65M |
| EPS | — | — | — | — | $-1.42 |
| Free cash flow | $-63.32M | $-76.32M | $-135.97M | $-216.89M | $-57.09M |
| Profit margin | -137.95% | -138.14% | -303.67% | -513.17% | — |
Peer comparison
Smart narrative
Ocular Therapeutix Inc trades at $9.21. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -2.07, it sits in the distress. TTM revenue stands at $51.95M.
Frequently asked questions
What is Ocular Therapeutix Inc's stock price?
Ocular Therapeutix Inc (OCUL) trades at $9.21.
Is Ocular Therapeutix Inc overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Ocular Therapeutix Inc (OCUL)?
The analyst target price is $26.00, representing +182.3% upside from the current price of $9.21.
What is Ocular Therapeutix Inc's revenue?
TTM revenue is $51.95M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-2.07 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio38.59x
ROE-54.80%
Beta0.95
50D MA$8.93
200D MA$11.06
Shares out0.22B
Float0.22B
Short ratio—
Avg volume4.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—